Johnson & Johnson (NYSE:JNJ)
Market Cap | 0 |
---|---|
Revenue | 95.33B |
Gross Profit | 64.36B |
Shares Out | 2.41B |
EPS (ttm) | 13.26 |
PE Ratio | 10.2377 |
Forward PE | 14.0060 |
Dividend Rate (ttm) | 4.5904 |
Dividend Yield | 0.0312 |
Trading Day | Nov 29 |
---|---|
Last Price | $0.00 |
Previous Close | $0.00 |
Change ($) | |
Change (%) | % |
Day's Open | $Market Closed |
Day's Range | $ + $0 |
Day's Volume | 0 |
52 Week Range | $N.A - $N.A |
About Johnson & Johnson
NYSE:JNJ stock is currently trading at $0.00 as of 12:00 AM UTC, Jan 1, 1970. Use the financials tab to find out more about Johnson & Johnson's key financial metrics and recent earnings reports, or track its share price in real time on the chart tab. If you would like to buy shares in Johnson & Johnson, our detailed guide explains how to buy Johnson & Johnson stock.
News
Quick info
New Brunswick
New Jersey
08933-0001
Johnson & Johnson income statements (2023)
October 2023 | July 2023 | April 2023 | |
---|---|---|---|
Total Revenue | 21.35B | 25.53B | 24.75B |
Cost of Revenue | 6.61B | 8.21B | 8.40B |
Gross Profit | 14.75B | 17.32B | 16.35B |
Research & Development | 3.45B | 3.83B | 3.56B |
Selling General & Admin | 5.40B | 6.67B | 6.14B |
Operating Expense | N.A | N.A | N.A |
Operating Income | 5.90B | 6.82B | 6.65B |
Other Income Expense Net | 0 | 0 | 0 |
EBIT | 5.90B | 6.82B | 6.65B |
Interest Income | 0 | 0 | 0 |
Pretax Income | 5.22B | 6.76B | 0 |
Income Tax | 0.91B | 1.62B | 0 |
Minority Interest | 0 | 0 | 0 |
Net Income | 26.03B | 5.14B | 0 |
Net Income Basic | 26.03B | 5.14B | 0 |
Johnson & Johnson income statements (2022)
February 2023 | October 2022 | July 2022 | |
---|---|---|---|
Total Revenue | 23.71B | 23.79B | 24.02B |
Cost of Revenue | 7.77B | 7.81B | 7.92B |
Gross Profit | 15.94B | 15.98B | 16.10B |
Research & Development | 3.84B | 3.60B | 3.70B |
Selling General & Admin | 6.51B | 6.09B | 6.23B |
Operating Expense | N.A | N.A | N.A |
Operating Income | 5.59B | 6.30B | 6.17B |
Other Income Expense Net | 0 | 0 | 0 |
EBIT | 5.59B | 6.30B | 6.17B |
Interest Income | 0 | 0 | 0 |
Pretax Income | 4.20B | 5.82B | 5.84B |
Income Tax | 681M | 1.36B | 1.03B |
Minority Interest | 0 | 0 | 0 |
Net Income | 3.52B | 4.46B | 4.81B |
Net Income Basic | 3.52B | 4.46B | 4.81B |
Johnson & Johnson balance sheet (2023)
October 2023 | July 2023 | April 2023 | February 2023 | |
---|---|---|---|---|
Current Cash | 23.51B | 28.51B | 24.61B | 23.52B |
Receivables | 14.80B | 16.78B | 16.35B | 16.16B |
Inventory | 11.20B | 12.89B | 12.81B | 12.48B |
Current Assets | 53.70B | 60.57B | 64.39B | 55.29B |
Other Current Assets | 4.20B | 2.40B | 2.92B | 3.13B |
Short Term Investments | 4.20B | 2.40B | 2.92B | 3.13B |
Long Term Investments | 112.36B | 131.12B | 131.58B | 132.08B |
Property/Plant Equipment | 18.82B | 20.58B | 20.17B | 19.80B |
Good Will | 36.12B | 45.44B | 45.58B | 45.23B |
Intangible Assets | 35.02B | 46.25B | 47.45B | 48.33B |
Tangible Assets (Net) | 83M | 0 | 0 | 0 |
Other Assets | 13.13B | 10.08B | 9.57B | 9.03B |
Total Assets | 166.06B | 191.69B | 195.97B | 187.38B |
Accounts Payable | 8.36B | 10.44B | 9.91B | 11.70B |
Other Current Liabilities | 32.15B | 32.03B | 32.49B | 31.33B |
Total Current Liabilities | 44.37B | 54.17B | 60.37B | 55.80B |
Total Liabilities | 94.83B | 116.54B | 125.10B | 110.57B |
Long Term Debt | 26.05B | 33.90B | 34.93B | 26.89B |
Current Long Term Debt | 3.87B | 11.70B | 17.98B | 12.77B |
Minority Interest | 0 | 1.26B | 0 | 0 |
Common Stock | 2.52B | 2.60B | 2.61B | 2.61B |
Treasury Stock | 0 | 0 | 0 | 0 |
Retained Earnings | 152.54B | 129.38B | 124.56B | 128.35B |
Capital Surplus | N.A | N.A | N.A | N.A |
Shareholder Equity | 71.23B | 75.15B | 70.87B | 76.80B |
Other Liabilities | 21.79B | 23.58B | 25.38B | 21.51B |
Johnson & Johnson balance sheet (2022)
October 2022 | July 2022 | |
---|---|---|
Current Cash | 34.08B | 32.57B |
Receivables | 15.89B | 16.14B |
Inventory | 11.68B | 11.44B |
Current Assets | 65.24B | 63.85B |
Other Current Assets | 3.59B | 3.70B |
Short Term Investments | 3.59B | 3.70B |
Long Term Investments | 109.89B | 113.88B |
Property/Plant Equipment | 18.15B | 18.35B |
Good Will | 33.38B | 34.17B |
Intangible Assets | 40.34B | 42.41B |
Tangible Assets (Net) | 880M | 0 |
Other Assets | 8.63B | 9.44B |
Total Assets | 175.12B | 177.72B |
Accounts Payable | 10.15B | 9.77B |
Other Current Liabilities | 30.97B | 30.75B |
Total Current Liabilities | 45.54B | 44.82B |
Total Liabilities | 100.53B | 101.37B |
Long Term Debt | 27.60B | 28.29B |
Current Long Term Debt | 4.42B | 4.31B |
Minority Interest | 0 | 0 |
Common Stock | 2.63B | 2.63B |
Treasury Stock | 0 | 0 |
Retained Earnings | 127.92B | 126.22B |
Capital Surplus | N.A | N.A |
Shareholder Equity | 74.60B | 76.36B |
Other Liabilities | 22.43B | 23.24B |
Johnson & Johnson cash flow (2023)
October 2023 | July 2023 | April 2023 | February 2023 | October 2022 | July 2022 | |
---|---|---|---|---|---|---|
Net Income | 26.03B | 5.14B | 0 | 3.52B | 4.46B | 4.81B |
Depreciation | 1.83B | 1.93B | 1.88B | 1.77B | 1.69B | 1.74B |
Changes in Receivables | 14.80B | 16.78B | 16.35B | 16.16B | 15.89B | 16.14B |
Changes in Inventories | 11.20B | 12.89B | 12.81B | 12.48B | 11.68B | 11.44B |
Cash Change | 23.51B | 28.51B | 24.61B | 23.52B | 34.08B | 32.57B |
Cash Flow | 7.49B | 4.18B | 3.26B | 5.35B | 6.28B | 5.58B |
Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | N.A | N.A | N.A | N.A | N.A | N.A |
Investing Activity (other) | N.A | N.A | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | 2.54B | 0 | 3.32B | 0 | 0 | 0 |
Dividends Paid | N.A | N.A | N.A | N.A | N.A | N.A |
Net Borrowings | 2.21B | 14.70B | 25.37B | 13.01B | 0 | 0 |
Other Financing Cash Flows | N.A | N.A | N.A | N.A | N.A | N.A |
Cash Flow Financing | 0 | 0 | 6.14B | 1.70B | 0 | 0 |
Exchange Rate Effect | N.A | N.A | N.A | N.A | N.A | N.A |
Johnson & Johnson dividends
Ex date | Payment date | Record date | Declared date | Amount | Description | Frequency |
---|---|---|---|---|---|---|
20-11-2023 | 05-12-2023 | 21-11-2023 | 19-10-2023 | 1.19 | Ordinary Shares | Quarterly |
25-08-2023 | 07-09-2023 | 28-08-2023 | 20-07-2023 | 1.19 | Ordinary Shares | Quarterly |
22-05-2023 | 06-06-2023 | 23-05-2023 | 18-04-2023 | 1.19 | Ordinary Shares | Quarterly |
17-02-2023 | 07-03-2023 | 21-02-2023 | 03-01-2023 | 1.13 | Ordinary Shares | Quarterly |
21-11-2022 | 06-12-2022 | 22-11-2022 | 19-10-2022 | 1.13 | Ordinary Shares | Quarterly |
22-08-2022 | 06-09-2022 | 23-08-2022 | 18-07-2022 | 1.13 | Ordinary Shares | Quarterly |
Total Valuation
has a market cap or net worth of $0. The enterprise value is $360.88 billion.
Important Dates
Share Statistics
has 2.41 billion shares outstanding.
Valuation Ratios
The trailing PE ratio is 10.2377 and the forward PE ratio is 14.0060. 's PEG ratio is 0.1208.
Stock Price Statistics
The stock price has increased by -0.1050%. The beta is 0.0000, so 's price volatility has been lower than the market average.
Income Statement
In the last 12 months, had revenue of $95.33 billion and earned $64.36 billion in profits. Earnings per share was $13.26.
About
New Brunswick
New Jersey
08933-0001